PlainRecalls
FDA Drug Moderate Class II Terminated

Docetaxel Injection USP, 80 mg/4 mL, (20 mg/mL), One-Vial Formulation, Rx only, Mfd By: Dr. Reddy's Laboratories Limited, Visakhapatnam - 530 046, Andhra Pradesh, INDIA, NDC 43598-259-40.

Reported: March 20, 2019 Initiated: March 6, 2019 #D-1001-2019

Product Description

Docetaxel Injection USP, 80 mg/4 mL, (20 mg/mL), One-Vial Formulation, Rx only, Mfd By: Dr. Reddy's Laboratories Limited, Visakhapatnam - 530 046, Andhra Pradesh, INDIA, NDC 43598-259-40.

Reason for Recall

Defective Container: complaint for seal and cap vial issues that could lead to a lack of sterility assurance.

Details

Units Affected
5,755 vials
Distribution
Nationwide in the USA
Location
Princeton, NJ

Frequently Asked Questions

What product was recalled?
Docetaxel Injection USP, 80 mg/4 mL, (20 mg/mL), One-Vial Formulation, Rx only, Mfd By: Dr. Reddy's Laboratories Limited, Visakhapatnam - 530 046, Andhra Pradesh, INDIA, NDC 43598-259-40.. Recalled by Dr. Reddy's Laboratories, Inc.. Units affected: 5,755 vials.
Why was this product recalled?
Defective Container: complaint for seal and cap vial issues that could lead to a lack of sterility assurance.
Which agency issued this recall?
This recall was issued by the FDA Drug on March 20, 2019. Severity: Moderate. Recall number: D-1001-2019.